134 related articles for article (PubMed ID: 8991117)
21. Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature.
Meehan KR; Pritchard RS; Leichter JW; Littenberg B; Welch HG
Am J Hematol; 1995 Oct; 50(2):116-23. PubMed ID: 7572990
[TBL] [Abstract][Full Text] [Related]
22. High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma.
McCann JC; Kanteti R; Shilepsky B; Miller KB; Sweet M; Schenkein DP
Biol Blood Marrow Transplant; 1996 Feb; 2(1):37-43. PubMed ID: 9078353
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphoma.
Maloney DG
Curr Opin Hematol; 1995 Jul; 2(4):255-61. PubMed ID: 9372005
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation as consolidation therapy in newly diagnosed non-Hodgkin's lymphoma: long-term outcome.
Montuoro A; Lalle M; Ingletto D
Int J Oncol; 2000 Oct; 17(4):771-5. PubMed ID: 10995890
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: issues and controversies.
Bierman PJ; Vose JM; Armitage JO
Leukemia; 1991; 5 Suppl 1():58-62. PubMed ID: 1890868
[No Abstract] [Full Text] [Related]
26. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
27. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
28. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
[TBL] [Abstract][Full Text] [Related]
29. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
Haioun C; Lepage E; Gisselbrecht C; Coiffier B; Bosly A; Tilly H; Morel P; Nouvel C; Herbrecht R; D'Agay MF
J Clin Oncol; 1994 Dec; 12(12):2543-51. PubMed ID: 7527453
[TBL] [Abstract][Full Text] [Related]
30. The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.
Prince HM; Imrie K; Crump M; Stewart AK; Girouard C; Colwill R; Brandwein J; Tsang RW; Scott JG; Sutton DM; Pantalony D; Carstairs K; Sutcliffe SB; Keating A
Br J Haematol; 1996 Mar; 92(4):880-9. PubMed ID: 8616081
[TBL] [Abstract][Full Text] [Related]
31. [Autologous bone marrow transplantation as early therapy for patients with aggressive non-Hodgkin's lymphoma].
Havemann K; Kaiser U
Strahlenther Onkol; 1996 Jan; 172(1):50-1. PubMed ID: 8571191
[No Abstract] [Full Text] [Related]
32. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
Williams CD; Harrison CN; Lister TA; Norton AJ; Blystad AK; Coiffier B; Taghipour G; Schmitz N; Goldstone AH;
J Clin Oncol; 2001 Feb; 19(3):727-35. PubMed ID: 11157024
[TBL] [Abstract][Full Text] [Related]
33. Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma.
Moreau P; LeTortorec S; Mahé MA; Mahé B; Moreau A; Bourdin S; Bulabois CE; Bureau B; Harousseau JL; Milpied N
Bone Marrow Transplant; 1994 Nov; 14(5):775-8. PubMed ID: 7889011
[TBL] [Abstract][Full Text] [Related]
34. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
35. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
Shim BY; Lee MA; Byun JH; Roh SY; Song CW; Park JN; Lee JW; Min WS; Hong YS; Kim CC
Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
Seymour JF
N Engl J Med; 1995 Sep; 333(11):727; author reply 730. PubMed ID: 7637754
[No Abstract] [Full Text] [Related]
37. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.
Mills W; Chopra R; McMillan A; Pearce R; Linch DC; Goldstone AH
J Clin Oncol; 1995 Mar; 13(3):588-95. PubMed ID: 7884420
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of non-Hodgkin's aggressive lymphomas.
Salles G; Shipp MA; Coiffier B
Semin Hematol; 1994 Jan; 31(1):46-69. PubMed ID: 8122135
[No Abstract] [Full Text] [Related]
39. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
40. Salvage therapy for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Bierman P; Armitage JO
Oncology (Williston Park); 1987 Nov; 1(9):11-21. PubMed ID: 3079492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
